Immune checkpoint blockade therapy for esophageal squamous cell carcinoma

Kazuto Harada; Dilsa Mizrak Kaya; Hideo Baba; Jaffer A. Ajani

doi:10.21037/jtd.2018.01.120

Immune checkpoint blockade therapy for esophageal squamous cell carcinoma

Kazuto Harada, Dilsa Mizrak Kaya, Hideo Baba, Jaffer A. Ajani

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	699-702
Number of pages	4
Journal	Journal of Thoracic Disease
Volume	10
Issue number	2
DOIs	https://doi.org/10.21037/jtd.2018.01.120
State	Published - Feb 1 2018

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.21037/jtd.2018.01.120

Cite this

@article{cb52f7eb502f464495b8ecca8a18ca2b,

title = "Immune checkpoint blockade therapy for esophageal squamous cell carcinoma",

author = "Kazuto Harada and Kaya, {Dilsa Mizrak} and Hideo Baba and Ajani, {Jaffer A.}",

note = "Funding Information: This research was supported by generous grants from the Caporella, Dallas, Sultan, Park, Smith, Frazier, Oaks, Vanstekelenberg, Planjery, and Cantu families, as well as from the Schecter Private Foundation, Rivercreek Foundation, Kevin Fund, Myer Fund, Dio Fund, Milrod Fund, and The University of Texas MD Anderson Cancer Center (Houston, Texas, USA) multidisciplinary grant program. This research was also supported in part by the National Cancer Institute: CA129906, CA 127672, CA138671, and CA172741 and the Department of Defense awards: CA150334 and CA162445 (JA Ajani), and by a grant from the Japan Society for the Promotion of Science Overseas Research Fellowships and Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (K Harada) Funding Information: Funding: This research was supported by generous grants",

year = "2018",

month = feb,

day = "1",

doi = "10.21037/jtd.2018.01.120",

language = "English (US)",

volume = "10",

pages = "699--702",

journal = "Journal of Thoracic Disease",

issn = "2072-1439",

publisher = "Pioneer Bioscience Publishing Company (PBPC)",

number = "2",

}

TY - JOUR

T1 - Immune checkpoint blockade therapy for esophageal squamous cell carcinoma

AU - Harada, Kazuto

AU - Kaya, Dilsa Mizrak

AU - Baba, Hideo

AU - Ajani, Jaffer A.

N1 - Funding Information: This research was supported by generous grants from the Caporella, Dallas, Sultan, Park, Smith, Frazier, Oaks, Vanstekelenberg, Planjery, and Cantu families, as well as from the Schecter Private Foundation, Rivercreek Foundation, Kevin Fund, Myer Fund, Dio Fund, Milrod Fund, and The University of Texas MD Anderson Cancer Center (Houston, Texas, USA) multidisciplinary grant program. This research was also supported in part by the National Cancer Institute: CA129906, CA 127672, CA138671, and CA172741 and the Department of Defense awards: CA150334 and CA162445 (JA Ajani), and by a grant from the Japan Society for the Promotion of Science Overseas Research Fellowships and Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (K Harada) Funding Information: Funding: This research was supported by generous grants

PY - 2018/2/1

Y1 - 2018/2/1

UR - http://www.scopus.com/inward/record.url?scp=85042096385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042096385&partnerID=8YFLogxK

U2 - 10.21037/jtd.2018.01.120

DO - 10.21037/jtd.2018.01.120

M3 - Editorial

C2 - 29607137

AN - SCOPUS:85042096385

SN - 2072-1439

VL - 10

SP - 699

EP - 702

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

IS - 2

ER -

Immune checkpoint blockade therapy for esophageal squamous cell carcinoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this